Jasmine Pereira, | |
652 Forest Ave, Palo Alto, CA 94301-2622 | |
(650) 323-1401 | |
(408) 642-6052 |
Full Name | Jasmine Pereira |
---|---|
Gender | Female |
Speciality | Case Manager/care Coordinator |
Location | 652 Forest Ave, Palo Alto, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023679966 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Secondary |
171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jasmine Pereira, 1922 The Alameda Ste 316, San Jose, CA 95126-1461 Ph: (408) 261-7777 | Jasmine Pereira, 652 Forest Ave, Palo Alto, CA 94301-2622 Ph: (650) 323-1401 |
News Archive
Northwestern Engineering researchers have developed a new way to manipulate a virus shell that self-assembles from proteins and holds promise as a carrier for disease detection, drug delivery, and vaccinations.
The Food and Drugs Administration (FDA) has announced that in the beginning of November, the diabetes drug Avandia will no longer be sold in pharmacy shelves, due to the cardiovascular risks it's causing its patients.
Align Technology, Inc. today announced the launch of Invisalign® G3, the most significant collection of new features and innovations in the company's history. Invisalign G3 is engineered to deliver even better clinical results, with new aligner and software features that make it easier to use Invisalign with Class II and Class III patients, new SmartForce™ features designed for increased predictability of certain tooth movements, and simpler, more intuitive software to streamline treatment planning and review.
Los Angeles, London, New Delhi, Singapore and Washington DC (October 13, 2009) The American Society for Aesthetic Plastic Surgery (ASAPS) has partnered with SAGE to publish the Aesthetic Surgery Journal (ASJ) beginning in 2010.
Cancer diagnostics company Biomoda, Inc. (www.biomoda.com) and Obio, Inc., a corporation formed to pursue public and private funding for cancer research in Ohio, are working together to expand Biomoda's lung cancer screening program for veterans into Ohio.
› Verified 3 days ago